Resink A, Villa M, Benke D, Hidaka H, Möhler H, Balázs R
Institute of Pharmacology, ETH, Switzerland.
J Neurochem. 1996 Jan;66(1):369-77. doi: 10.1046/j.1471-4159.1996.66010369.x.
Exposure of cerebellar granule cells to NMDA in culture at 5 days in vitro, when cells are not yet vulnerable to NMDA, evoked a pronounced reduction in NMDA receptor activity, measured by NMDA-induced 45Ca2+ influx, and counteracted the normal developmental increase in NMDA receptors. The effect was concentration and time dependent, the half-maximal effect being reached at about 45 microM and by 4-5 h. The decrease in NMDA receptor function was accompanied by a significant reduction in the protein level of the obligatory NMDA receptor subunit (NR) NR1. Both parameters remained at a low level as long as the agonist was present. However, receptor down-regulation was reversible, as receptor protein levels and NMDA responses were restored to control values upon NMDA removal, this process requiring protein synthesis. NMDA treatment also elicited a decrease in NR1, NR2A, and NR2B subunit messenger RNA (mRNA) levels. However, in comparison with NMDA receptor proteins, the decrease was faster, and NMDA receptor mRNA content recovered to control levels within 24 h in spite of the presence of NMDA. Concerning the mechanisms of agonist-induced regulation of NMDA receptor expression, it seems that protein kinase C-mediated protein phosphorylation is not involved, whereas inhibition of Ca2+/calmodulin-dependent kinase II/IV by KN-62 does depress NMDA receptor expression even in the absence of NMDA.
在体外培养5天时,将小脑颗粒细胞暴露于NMDA中,此时细胞对NMDA尚不敏感,结果发现,通过NMDA诱导的45Ca2+内流测量,NMDA受体活性显著降低,并且抵消了NMDA受体正常的发育性增加。该效应具有浓度和时间依赖性,在约45微摩尔时达到半数最大效应,4至5小时后完全显现。NMDA受体功能的降低伴随着必需的NMDA受体亚基(NR)NR1蛋白水平的显著降低。只要激动剂存在,这两个参数就保持在低水平。然而,受体下调是可逆的,因为在去除NMDA后,受体蛋白水平和NMDA反应恢复到对照值,这一过程需要蛋白质合成。NMDA处理还导致NR1、NR2A和NR2B亚基信使核糖核酸(mRNA)水平降低。然而,与NMDA受体蛋白相比,降低速度更快,尽管存在NMDA,NMDA受体mRNA含量在24小时内恢复到对照水平。关于激动剂诱导的NMDA受体表达调节机制,似乎不涉及蛋白激酶C介导的蛋白质磷酸化,而KN-62对Ca2+/钙调蛋白依赖性激酶II/IV的抑制即使在没有NMDA的情况下也会抑制NMDA受体表达。